Skip to main content
OpenTrials

Clinical trial condition

Rectal Diseases

Explore clinical trials studying Rectal Diseases. Study availability and eligibility vary by location and protocol.

5,954 public trials 1,253 recruiting studies
Refine in advanced search Browse all conditions

Rectal Diseases trial results

Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

NCT05141721

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Highlands Oncology Springdale, Arkansas, United States
  • U.S.C Norris Cancer Center, Keck School of Medicine, Division of Medical Oncology Los Angeles, California, United States
  • University of California - Irvine (UCI) Orange, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

NCT05736731

Conditions
Bronchial Neoplasms, CRC, Cancer, +38 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy

NCT03908788

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • ICM Val d'Aurelle Montpellier, France
  • Institut du Cancer de Montpellier - Val d'Aurelle Montpellier, France
View Trial Details

Related conditions